Campbell & CO Investment Adviser LLC acquired a new position in shares of Safeguard Scientifics, Inc (NYSE:SFE) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 20,680 shares of the asset manager’s stock, valued at approximately $145,000.
A number of other institutional investors also recently bought and sold shares of SFE. BNP Paribas Arbitrage SA lifted its position in Safeguard Scientifics by 114.8% during the 1st quarter. BNP Paribas Arbitrage SA now owns 6,061 shares of the asset manager’s stock worth $34,000 after acquiring an additional 3,239 shares during the period. Requisite Capital Management LLC acquired a new stake in Safeguard Scientifics during the 1st quarter worth approximately $72,000. Engineers Gate Manager LP acquired a new stake in Safeguard Scientifics during the 1st quarter worth approximately $93,000. Los Angeles Capital Management & Equity Research Inc. acquired a new stake in Safeguard Scientifics during the 1st quarter worth approximately $192,000. Finally, Invesco Ltd. lifted its position in Safeguard Scientifics by 13.2% during the 1st quarter. Invesco Ltd. now owns 42,784 shares of the asset manager’s stock worth $237,000 after acquiring an additional 4,973 shares during the period. 70.72% of the stock is owned by institutional investors.
In other news, Director Joseph M. Jr. Manko acquired 16,229 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The stock was purchased at an average cost of $6.80 per share, with a total value of $110,357.20. Following the purchase, the director now directly owns 9,612 shares of the company’s stock, valued at approximately $65,361.60. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Joseph M. Jr. Manko acquired 10,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 6th. The stock was purchased at an average cost of $6.26 per share, with a total value of $62,600.00. Following the completion of the purchase, the director now directly owns 9,612 shares in the company, valued at $60,171.12. The disclosure for this purchase can be found here. Insiders purchased a total of 81,026 shares of company stock valued at $534,521 over the last ninety days. 6.40% of the stock is currently owned by company insiders.
SFE has been the subject of several recent analyst reports. Zacks Investment Research raised Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $8.00 price target for the company in a report on Thursday, June 18th. ValuEngine raised Safeguard Scientifics from a “sell” rating to a “hold” rating in a report on Monday, June 1st.
SFE opened at $5.69 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 6.78 and a quick ratio of 6.78. The business has a 50 day simple moving average of $6.43 and a 200-day simple moving average of $7.32. The stock has a market capitalization of $117.63 million, a P/E ratio of 3.90 and a beta of 1.44. Safeguard Scientifics, Inc has a 12 month low of $4.43 and a 12 month high of $12.79.
Safeguard Scientifics (NYSE:SFE) last posted its quarterly earnings results on Thursday, April 30th. The asset manager reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.34) by ($0.43).
About Safeguard Scientifics
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Recommended Story: What does a neutral rating on stocks mean?
Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics, Inc (NYSE:SFE).
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.